Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Amedisys Inc (AMED)

Amedisys Inc (AMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,271,045
  • Shares Outstanding, K 32,632
  • Annual Sales, $ 2,106 M
  • Annual Income, $ 183,610 K
  • 60-Month Beta 0.51
  • Price/Sales 2.59
  • Price/Cash Flow 22.08
  • Price/Book 6.82
Trade AMED with:

Options Overview Details

View History
  • Implied Volatility 39.22%
  • Historical Volatility 30.94%
  • IV Percentile 78%
  • IV Rank 42.10%
  • IV High 56.36% on 10/28/20
  • IV Low 26.76% on 06/09/21
  • Put/Call Vol Ratio 0.51
  • Today's Volume 187
  • Volume Avg (30-Day) 209
  • Put/Call OI Ratio 0.76
  • Today's Open Interest 1,277
  • Open Int (30-Day) 1,470

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 1.36
  • Number of Estimates 7
  • High Estimate 1.42
  • Low Estimate 1.28
  • Prior Year 2.24
  • Growth Rate Est. (year over year) -39.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
154.52 +0.54%
on 09/24/21
187.53 -17.16%
on 09/02/21
-26.97 (-14.79%)
since 08/24/21
3-Month
154.52 +0.54%
on 09/24/21
276.21 -43.76%
on 07/07/21
-88.10 (-36.19%)
since 06/24/21
52-Week
154.52 +0.54%
on 09/24/21
325.12 -52.22%
on 01/25/21
-69.24 (-30.83%)
since 09/24/20

Most Recent Stories

More News
Here's Why You Should Hold on to LHC Group (LHCG) Stock Now

LHC Group (LHCG) continues to benefit from strategic deals and broad array of services.

AMED : 155.35 (-3.83%)
HSIC : 78.10 (+0.64%)
LHCG : 160.27 (-0.38%)
NVST : 43.28 (+1.45%)
Amedisys to Acquire Home Health Regulatory Assets in Charlotte and Raleigh, N.C.

Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice and personal care, has signed a definitive agreement to acquire regulatory assets that allow the Company to establish home...

AMED : 155.35 (-3.83%)
EHC or AMED: Which Is the Better Value Stock Right Now?

EHC vs. AMED: Which Stock Is the Better Value Option?

EHC : 77.01 (+0.86%)
AMED : 155.35 (-3.83%)
Encompass Health's (EHC) Growth View Makes It a Good Buy

Ageing population, building of hospitals and other operational efforts poise Encompass Health (EHC) well for long-term growth, thus making it a good investment option.

AMED : 155.35 (-3.83%)
DVA : 121.00 (-0.90%)
LHCG : 160.27 (-0.38%)
EHC : 77.01 (+0.86%)
EHC vs. AMED: Which Stock Should Value Investors Buy Now?

EHC vs. AMED: Which Stock Is the Better Value Option?

EHC : 77.01 (+0.86%)
AMED : 155.35 (-3.83%)
Here's Why You Should Hold on to LHC Group (LHCG) Stock Now

LHC Group (LHCG) continues to benefit from strategic deals and broad array of services.

AMED : 155.35 (-3.83%)
HSIC : 78.10 (+0.64%)
LHCG : 160.27 (-0.38%)
NVST : 43.28 (+1.45%)
EHC vs. AMED: Which Stock Should Value Investors Buy Now?

EHC vs. AMED: Which Stock Is the Better Value Option?

EHC : 77.01 (+0.86%)
AMED : 155.35 (-3.83%)
Amedisys (AMED) Suffers From Low Occupancy Amid Pandemic

The prolonged and lingering impact of COVID-19 on Amedisys (AMED) Hospice business has hampered its ability to grow at the earlier-projected rates.

AMED : 155.35 (-3.83%)
ISRG : 1,043.33 (-0.14%)
IDXX : 679.64 (-0.43%)
SMLR : 115.5000 (-1.28%)
Amedisys (AMED) Q2 Earnings Beat Estimates, Margins Grow

Amedisys (AMED) reports better-than-expected earnings for the second quarter with strong performance in Home Health and Hospice segments.

AMED : 155.35 (-3.83%)
WST : 457.11 (+0.42%)
BRKR : 84.58 (-0.34%)
EHC : 77.01 (+0.86%)
Amedisys (AMED) Beats Q2 Earnings Estimates

Amedisys (AMED) delivered earnings and revenue surprises of 3.05% and -0.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

AMED : 155.35 (-3.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Amedisys, Inc. is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients. From home health to hospice to personal care, Amedisys team members provide quality, clinically-distinctive care to patients every year. Amedisys is focused on delivering the care...

See More

Key Turning Points

3rd Resistance Point 163.41
2nd Resistance Point 161.47
1st Resistance Point 158.41
Last Price 155.35
1st Support Level 153.41
2nd Support Level 151.46
3rd Support Level 148.40

See More

52-Week High 325.12
Fibonacci 61.8% 259.95
Fibonacci 50% 239.82
Fibonacci 38.2% 219.69
Last Price 155.35
52-Week Low 154.52

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar